MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    Pain and symptom management in a case of cervical dystonia with comorbid generalized joint hypermobility using prolotherapy with osteopathic manipulative medicine

    J. Mancini, D. Whitfield (Old Westbury, USA)

    Objective: To improve pain and quality of life in cervical dystonia (CD) with comorbid generalized joint hypermobility (GJH) using prolotherapy with osteopathic manipulative medicine (OMM).…
  • MDS Virtual Congress 2021

    Combined dystonia in a patient carrying a novel ATL1 gene variant.

    M. Gea, K. Beyer, F. Nuñez, L. Ispierto, R. álvarez, G. Lucente, D. Vilas (Badalona, Spain)

    Objective: To describe a patient with a childhood-onset combined dystonia who was found to be a carrier of a novel mutation in the ATL1 gene.…
  • MDS Virtual Congress 2021

    Comprehensive analysis of non-motor symptoms and their association with quality of life in writer’s cramp

    LY. Zhang, YB. Hou, J. Yang, B. Cao, HF. Shang (Chengdu, China)

    Objective: The current study aimed to examine the frequency of non-motor symptoms and their association with quality of life in patients with writer’s cramp. Background:…
  • MDS Virtual Congress 2021

    Implementing a Neuropalliative Care Curriculum for Neurology Residents Focused on Neurodegenerative Diseases

    O. Dubaz, J. Hauser (Boston, USA)

    Objective: To implement a neuropalliative care curriculum for neurology residents in order to increase comfort with palliative and hospice care topics for patients with progressive…
  • MDS Virtual Congress 2021

    Is the association between cigarette smoking and Parkinson disease causal? A Mendelian Randomization study.

    C. Domenighetti, PE. Sugier, A. Ashokkumar Sreelatha, C. Schulte, S. Grover, O. Mohamed, B. Portugal, P. May, D. Bobbili, M. Radivojkov-Blagojevic, P. Lichtner, R. Krüger, T. Gasser, M. Sharma, A. Elbaz (Villejuif Cedex, France)

    Objective: To determine whether the association between cigarette smoking and Parkinson disease (PD) is causal using 2-sample Mendelian randomization (MR) and to examine the potential…
  • MDS Virtual Congress 2021

    Body mass index and incidence of Parkinson’s disease in French women from the E3N cohort study

    B. Portugal, F. Artaud, C. Domenighetti, E. Roze, I. Dagaey, M. Canonico, A. Elbaz (Villejuif, France)

    Objective: We examined the association between BMI and PD incidence in women from the E3N cohort with repeated BMI measures over 29 years of follow-up,…
  • MDS Virtual Congress 2021

    Association between adverse childhood experiences and functional seizures among FND patients in the FND Patient Registry

    B. Mildon, E. Snow, J. Occean, N. Agu, A. Salinas-Miranda (Salmon, USA)

    Objective: This analysis examined the association between adverse childhood experiences (ACE) and functional seizures among FND patients. Background: Functional seizures are seizures of undetermined organic…
  • MDS Virtual Congress 2021

    Cumulative Real-World Experience with Deutetrabenazine for Huntington’s Disease Chorea at a Single Center of Excellence in the US

    K. Curtis, B. Denson, V. Sung (Birmingham, USA)

    Objective: To summarize clinical experience and outcomes with deutetrabenazine (DTBZ) as a treatment for Huntington’s disease (HD) chorea from the Huntington’s Disease Society of America…
  • MDS Virtual Congress 2021

    A screening tool to assess telehealth suitability among patients with Huntington’s disease

    S. Lee, L. Hale, K. Mcdonell (Nashville, USA)

    Objective: To evaluate a screening tool to assess telehealth (TH) suitability among Huntington’s disease (HD) patients Background: Extenuating patient circumstances [1] and COVID-19 necessitate greater…
  • MDS Virtual Congress 2021

    Visual cognition differences between asymptomatic and symptomatic carriers of Huntington’s disease (HD)

    M. Turuelo, MA. Acera, M. Diez-Cirarda, T. Fernández, B. Tijero, M. Carmona, M. Ruiz, J. Somme, J. Ruiz, A. Gabilondo, I. Croitoru, L. Pardina, N. Ayo, A. Murueta-Goyena, I. Gabilondo, JC. Gómez-Esteban, R. Del Pino (Barakaldo, Spain)

    Objective: This study aims to analyze the visual cognition profile of asymptomatic and symptomatic carriers of Huntington's disease (HD), compared with healthy controls (HC), and…
  • « Previous Page
  • 1
  • …
  • 49
  • 50
  • 51
  • 52
  • 53
  • …
  • 132
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley